HealthcareServices

Excessive Daytime Sleepiness Industry Poised for Rapid Growth, Forecast to Touch $8.52 Billion by 2030 at 9.6% CAGR

March 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the excessive daytime sleepiness market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Excessive Daytime Sleepiness Market between 2026 and 2030?

The market for excessive daytime sleepiness has demonstrated strong growth in recent years. It is projected to increase from $5.39 billion in 2025 to $5.9 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.4%. The growth observed in the historical period is attributable to the rising prevalence of sleep disorders, an increased understanding of sleep health impacts, the expansion of sleep clinic infrastructure, the availability of pharmacological wake-promoting agents, and the broader provision of diagnostic sleep testing services.

The excessive daytime sleepiness market is projected to experience robust expansion over the next few years. It is set to reach $8.52 billion by 2030, advancing at a compound annual growth rate (CAGR) of 9.6%. This expected growth during the forecast period stems from factors such as increasing demand for personalized sleep treatment plans, rising integration of digital therapeutics in sleep care, wider adoption of remote patient monitoring, a growing emphasis on preventive sleep healthcare, and increasing investment in sleep medicine research. Significant trends anticipated during this period include the rising acceptance of wearable sleep monitoring devices, a growing utilization of combination therapy approaches, the expansion of home-based sleep disorder management, an increasing focus on early diagnosis and screening programs, and enhanced integration of digital sleep health platforms.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33109&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Excessive Daytime Sleepiness Market?

An anticipated increase in the occurrence of obstructive sleep apnea (OSA) is projected to boost the expansion of the excessive daytime sleepiness (EDS) market in the coming years. OSA is a sleep condition marked by recurrent breathing interruptions during rest, stemming from upper airway obstruction, which results in disrupted and lower-quality sleep. The incidence of OSA is on the rise, primarily attributed to increasing obesity levels. This leads to additional fat deposits around the neck and throat, constricting the airway and causing breathing to stop periodically during sleep. EDS presents as a widespread and debilitating manifestation of OSA, frequently lingering in a substantial number of individuals, thereby necessitating specific treatments and management approaches. To illustrate, information from August 2026, released by the National Library of Medicine, a US-based medical library, indicates that by 2050, around 76.6 million adults in the United States, aged 30–69, are predicted to suffer from obstructive sleep apnea. Consequently, this increasing prevalence of obstructive sleep apnea is fueling the expansion of the excessive daytime sleepiness market.

What Segments Are Included Within The Excessive Daytime Sleepiness Market?

The excessive daytime sleepiness market covered in this report is segmented –

1) By Treatment Type: Pharmacological Treatment; Behavioral Therapy; Continuous Positive Airway Pressure Therapy; Lifestyle Modification Programs; Combination Therapies

2) By Diagnosis Method: Polysomnography; Multiple Sleep Latency Test; Actigraphy; Clinical Evaluation; Questionnaire Based Assessments

3) By Type Of Disorder: Narcolepsy; Obstructive Sleep Apnea; Insomnia; Circadian Rhythm Disorders; Idiopathic Hypersomnia; Restless Legs Syndrome; Other Type Of Disorders

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

5) By End User: Hospitals; Sleep Clinics; Ambulatory Surgical Centers; Home Care Settings

Subsegments:

1) By Pharmacological Treatment: Wake Promoting Medications; Central Nervous System Stimulant Medications; Dopamine Reuptake Inhibitor Medications; Histamine Receptor Modulating Medications

2) By Behavioral Therapy: Cognitive Behavioral Therapy For Sleep; Sleep Hygiene Education Programs; Stimulus Control Therapy; Sleep Restriction Therapy

3) By Continuous Positive Airway Pressure Therapy: Fixed Pressure Airway Therapy; Auto Adjusting Airway Therapy; Bilevel Airway Therapy; Adaptive Pressure Support Therapy

4) By Lifestyle Modification Programs: Sleep Schedule Regulation Programs; Diet And Nutrition Management Programs; Physical Activity And Exercise Programs; Stress Management And Relaxation Programs

5) By Combination Therapies: Medication And Behavioral Therapy Combinations; Airway Therapy And Lifestyle Modification Combinations; Medication And Airway Therapy Combinations; Integrated Multimodal Treatment Approaches

Which Trends Are Influencing The Development Of The Excessive Daytime Sleepiness Market?

Leading enterprises within the excessive daytime sleepiness market are prioritizing the creation of novel treatments, including central nervous system depressants, aimed at boosting patient wakefulness and elevating their quality of life. Such a substance functions by decreasing nervous system activity, leading to effects like sedation, a sense of calm, or the induction of sleep. An illustrative example is Amneal Pharmaceuticals Inc., a US-based pharmaceutical firm, which secured FDA approval in September 2025 for its sodium oxybate oral solution, designed to directly address excessive daytime sleepiness (EDS) in individuals with narcolepsy. This solution significantly improves the continuity of care by enabling virtual specialist appointments, remote dispensing of prescriptions, and broader patient access in remote or neglected areas. Its overarching objectives are to broaden accessibility, make treatment more affordable, and integrate established pharmaceutical therapies with modern digital and telehealth-based care approaches for managing excessive daytime sleepiness.

Who Are The Primary Competitors In The Global Excessive Daytime Sleepiness Market?

Major companies operating in the excessive daytime sleepiness market are Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Cleveland Clinic, EisAI Co. Ltd, Jazz Pharmaceuticals plc., Emory Healthcare Inc., Alkermes plc., Fisher & Paykel Healthcare Corporation Limited, Harmony Biosciences Holdings Inc., Medanta, Axsome Therapeutics Inc., Compumedics Limited, BIOPROJET, Apnimed Inc., Nox Health Inc., Somnogen Canada Inc., Suven Life Sciences Limited, Theranexus, XWPharma, NLS Pharmaceutics AG.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/excessive-daytime-sleepiness-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Excessive Daytime Sleepiness Market?

North America was the largest region in the excessive daytime sleepiness market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the excessive daytime sleepiness market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Excessive Daytime Sleepiness Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=33109&type=smp

Browse Through More Reports Similar to the Global Excessive Daytime Sleepiness Market 2026, By The Business Research Company

Insomnia Market Report 2026

https://www.thebusinessresearchcompany.com/report/insomnia-global-market-report

Sleep Testing Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleep-testing-services-global-market-report

Sleep Monitoring Apps Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleep-monitoring-apps-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795